NEURAXIS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NEURAXIS, INC. (NRXS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $639.80 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $639.80K, a 269.74% increase year-over-year.
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $329.43K, a 211.34% increase year-over-year.
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $173.04K.
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $105.81K.
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $596.85K.
- NEURAXIS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $27.32K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $639.80K 10-Q · filed 2026-08-11 | $969.24K derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $329.43K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $596.85K 10-K · filed 2026-03-19 | |||
| 2025-06-30 | $173.04K 10-Q · filed 2026-08-11 | $278.85K derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $105.81K 10-Q · filed 2026-08-11 | |||
| 2022-12-31 | $27.32K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $3.20K 10-Q · filed 2023-11-20 | $15.32K derived: sum of 2 quarters · filed 2023-11-20 | $27.32K derived: sum of 3 quarters · filed 2023-11-20 | |
| 2022-06-30 | $12.13K 10-Q · filed 2023-11-20 | $24.12K derived: sum of 2 quarters · filed 2023-11-20 | ||
| 2022-03-31 | $11.99K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |